Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.15 USD
Change Today -0.06 / -2.71%
Volume 99.9K
OGXI On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Cindy Jacobs Ph.D., M.D.

Chief Medical Officer and Executive Vice President, OncoGenex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. Cindy Jacobs, Ph.D., M.D., has been Executive Vice President and Chief Medical Officer of OncoGenex Pharmaceuticals, Inc. (also known as Oncogenex Technologies Inc.) since August 2008. Dr. Jacobs has more than 20 years of biotechnology industry experience. Dr. Jacobs served as Senior Vice President of Clinical Development and Chief Medical Officer at GSK Biologicals Seattle (formerly Corixa Corp.) now a subsidiary of GlaxoSmithKline, since January 2005, where she ...

Read Full Background

Corporate Headquarters*

1522- 217th Place SE
Bothell, Washington 98021

United States

Phone: 425-686-1500
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Washington State University-Pullman
Washington State University-Pullman
Unknown/Other Education
Montana State University
University of Washington School of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$403,142

Stock Options*

Restricted Stock Awards$338,783
Exercisable Options108,770
Unexercisable Options28,230
Total Number of Options137,000

Total Compensation*

Total Annual Cash Compensation$524,084
Total Short Term Compensation$403,142
Other Long Term Compensation$338,783
Total Calculated Compensation$1,035,702
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $2.15 USD -0.06


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at